DUBLIN--(BUSINESS WIRE)--The "Dry Powder Inhaler Devices Device Pipeline Study- Analysis of Devices under Development, Companies, Developments and Outlook" report has been added to ...

Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies" report has been added to ...

11th November 2014. Boston, MA, USA. DoseOne, LLC holds multiple patents and prepared to partner the most innovative DPIs available today, the DoseOne™ Single Dose Powder Inhaler. Development of the ...

Drug delivery specialists MicroDose Therapeutx, based in Monmouth Junction, NJ, produces a device called the MicroDose DPI (dry powder inhaler), which uses ...

The Global Dry Powder Inhaler Device Market is estimated to reach USD 952.44 Million by 2027, according to a new report by Reports and Data. Increasing incidences of hereditary diseases, lung ...

The Dry Powder Inhaler Market is poised for significant growth, with a market value of USD 20.83 billion in 2024, projected to climb to USD 29.95 billion by 2034, representing a steady CAGR of 3.70% ...

Dry powder inhalers (DPIs) have become a mainstay in the management of chronic pulmonary diseases such as chronic obstructive pulmonary disease and asthma. Their performance depends on a complex ...

Scientific research will highlight advances in dry powder inhaler (DPI) platform products, patient-centric design and formulation-device integration Company experts will share insights to help improve ...

The pros and cons to using a dry powder inhaler as treatment for chronic obstructive pulmonary disease. Neil Minkoff, MD: Dr Drummond, we’ve talked a little bit about the differences. You brought some ...

Please provide your email address to receive an email when new articles are posted on . A metered-dose inhaler was switched to a dry-powder inhaler in Veterans Affairs facilities. Veterans who did vs.